Contributor Page
Sieben IP
 
Email  |  Articles
Contact Details
Tel: +91 11 260 13721
A-60, GF, Panchsheel Enclave
New Delhi
110017
India
By Sieben IP
Salient features of New TM Rules 2017.
By Sieben IP
One of the largest drug maker Sun Pharmaceutical Industries achieved another milestone by recently acquiring a US-based injectable-product manufacturing and services company Pharmalucence.